These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7609253)

  • 21. [Remarkable improvement of anemia by administration of recombinant human erythropoietin in a patient with aplastic anemia].
    Misago M; Mori N; Hoshuyama T; Tsukada J; Morimoto I; Oda S; Chiba S; Eto S
    Rinsho Ketsueki; 1991 Aug; 32(8):912-4. PubMed ID: 1942534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic anemia after lung transplantation: treatment with human recombinant erythropoietin.
    End A; Ringl H; Grimm M; Schlick W; Schreiner W; Klepetko W; Wolner E
    Transplantation; 1994 Apr; 57(7):1142. PubMed ID: 8165717
    [No Abstract]   [Full Text] [Related]  

  • 23. [Recombinant human erythropoietin in the treatment of the anemia of gynecological tumor patients].
    Kurata H; Yoshiya N; Higashino M; Igarashi H; Kaneko T; Kodama S; Tanaka K
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2243-5. PubMed ID: 8239694
    [No Abstract]   [Full Text] [Related]  

  • 24. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia.
    Bessho M; Jinnai I; Matsuda A; Saito M; Hirashima K
    Int J Cell Cloning; 1990 Nov; 8(6):445-58. PubMed ID: 2273298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of anemia in myelodysplastic syndromes with recombinant human erythropoietin].
    Rodríguez JN; Prados D; Martino ML; Muñiz R
    Sangre (Barc); 1993 Aug; 38(4):340-1. PubMed ID: 8235952
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of the anemia of chronic renal failure.
    Erslev AJ
    Clin Nephrol; 1974; 2(5):174-8. PubMed ID: 4426139
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma.
    Zwaginga JJ; IJsseldijk MJ; de Groot PG; Kooistra M; Vos J; van Es A; Koomans HA; Struyvenberg A; Sixma JJ
    Thromb Haemost; 1991 Dec; 66(6):638-47. PubMed ID: 1665596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of pure red cell aplasia in systemic lupus erythematosus with erythropoietin.
    Orbach H; Ben-Yehuda A; Ben-Yehuda D; Manor D; Rubinow A; Naparstek Y
    J Rheumatol; 1995 Nov; 22(11):2166-9. PubMed ID: 8596164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute treatment with recombinant erythropoietin in patients with pre- and postoperative anemia: a clinical report.
    von Bormann B; Weiler J; Aulich S
    Clin Investig; 1994; 72(6 Suppl):S31-5. PubMed ID: 7950170
    [No Abstract]   [Full Text] [Related]  

  • 30. [Revolution in the treatment of chronic renal insufficiency anemia: the role of recombinant erythropoietin].
    Panas N; Turkowa M; Zgheib A; Krzesinski JM; Rorive G
    Rev Med Liege; 1990 Jun; 45(6):280-5. PubMed ID: 2367758
    [No Abstract]   [Full Text] [Related]  

  • 31. Pressure sore anemia: response to erythropoietin.
    Turba RM; Lewis VL; Green D
    Arch Phys Med Rehabil; 1992 May; 73(5):498-500. PubMed ID: 1580782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
    Lim VS
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):26-7. PubMed ID: 2356366
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of recombinant human erythropoietin on erythrocyte lines in patients with anemia and chronic renal insufficiency].
    Marisavljević D; Djukanović Lj; Lezajić V
    Srp Arh Celok Lek; 1992; 120(9-10):281-5. PubMed ID: 1306020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma].
    Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
    Rinsho Ketsueki; 1993 Aug; 34(8):919-27. PubMed ID: 8411646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical application of recombinant erythropoietin in anemic cancer patients.
    Henry DH
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin treatment of idiopathic myelofibrosis.
    Aloe Spiriti M; Latagliata R; Avvisati G; Battistel V; Montefusco E; Spadea A; Petti MC
    Haematologica; 1993; 78(6):371-3. PubMed ID: 8175031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human erythropoietin treatment of anemic cancer patients.
    Henry DH
    Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Improvement of the anemia associated with multiple myeloma and renal dysfunction by recombinant human erythropoietin].
    Nakata H; Matsuzaki M; Shimamoto Y; Yamaguchi M
    Rinsho Ketsueki; 1990 Oct; 31(10):1752-3. PubMed ID: 2255069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin: current status.
    Bunn HF
    Yale J Biol Med; 1990; 63(5):381-6. PubMed ID: 2293499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anemia in hemodialysis patients.
    Higgins MR; Grace M; Ulan RA; Silverberg DS; Bettcher KB; Dossetor JB
    Arch Intern Med; 1977 Feb; 137(2):172-6. PubMed ID: 836115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.